Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of June 2011, with the report dated June 21, 2011. The filing documents a corporate restructuring event involving the company's U.S. finance subsidiaries.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, or liquidity metrics. It focuses exclusively on a debt obligation transfer.
- Debt Instrument: 6.5% Senior Notes due 2017.
- Transaction Type: Asset acquisition and assumption of obligations.
Material Changes
On June 20, 2011, Fresenius Medical Care US Finance, Inc. ("FMC US Finance") acquired substantially all assets of FMC Finance III S.A. ("FMC Finance III"). Concurrently, FMC US Finance assumed the obligations of FMC Finance III under the 6.5% Senior Notes due 2017. This change was effected via a Supplemental Indenture dated June 20, 2011. Both entities involved are wholly-owned subsidiaries of the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. Regarding risks and contingencies, the document explicitly states that the Guarantors' guarantees (Fresenius Medical Care AG & Co. KGaA, Fresenius Medical Care Holdings, Inc., and Fresenius Medical Deutschland GmbH) for the 6.5% Senior Notes have not been amended and remain in full force and effect.
Investor Verification Checklist
- Verify the execution of the Supplemental Indenture dated June 20, 2011.
- Confirm the continued validity of guarantees provided by the parent company and other guarantors for the 6.5% Senior Notes.
- Review the Notice of Substitution of Issuer published by the Luxembourg Stock Exchange.